tiprankstipranks
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
PremiumPress ReleasesPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
2M ago
Precipio trading resumes
PremiumThe Fly
Precipio trading resumes
3M ago
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
PremiumPress Releases
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
3M ago
Precipio trading resumes
PremiumThe FlyPrecipio trading resumes
3M ago
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
PremiumPress Releases
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
3M ago
Precipio enters distribution agreement for IV-Cell, HemeScreen in Japan
PremiumThe Fly
Precipio enters distribution agreement for IV-Cell, HemeScreen in Japan
3M ago
Precipio price target lowered to $19 from $22.25 at Alliance Global Partners
PremiumThe FlyPrecipio price target lowered to $19 from $22.25 at Alliance Global Partners
5M ago
Precipio Announces Q3-2023 Shareholder Update Call
PremiumPress Releases
Precipio Announces Q3-2023 Shareholder Update Call
5M ago
Precipio trading resumes
PremiumThe Fly
Precipio trading resumes
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100